IMMUNOTHERAPEUTIC COMPOSITIONS BASED ON YEAST WITH BRACHYURY Russian patent published in 2017 - IPC A61K39/00 A61K36/06 A61K38/17 A61P35/00 

Abstract RU 2619850 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine, namely to immunology and can be used to slow or prevent metastatic progression of cancer. For this purpose, a subject is administered a composition comprising: a) a yeast carrier and b) a cancer antigen, comprising at least one antigen Brachyury, where Brachyury antigen comprises SEQ ID NO: 6, positions 2-435 in SEQ ID NO: 6, SEQ ID NO: 18, positions 2-435 in SEQ ID NO: 18 or an amino acid sequence that is at least 85% identical to SEQ ID NO: 18 and comprises a leucine substitution to valine at position 254. The group of inventions also relates to immunotherapeutic composition and the process for its preparation, as well as application of this composition for malignant tumor treatment. Application of Brachyury antigen comprising SEQ ID NO: 6, SEQ ID NO: 18, and yeast vectors provides a immunotherapeutic composition that ensures an increase of Brachyury specific T-cells (specific for Brachyury CD8+ CD4+ T-cells) upon administration.

EFFECT: invention allows to slow down and prevent metastatic progression of cancer.

98 cl, 12 ex, 10 tbl, 9 dwg

Similar patents RU2619850C2

Title Year Author Number
YEAST-BASED IMMUNOTHERAPEUTIC COMPOSITIONS WITH BRACHYURY 2012
  • Schlom, Jeffrey
  • Apelian, David
  • Guo, Zhimin
  • Palena, Claudia
RU2690180C2
IMMUNOTHERAPEUTIC COMPOSITIONS ON THE BASIS OF YEAST-MUC1 AND METHODS OF THEIR USE 2012
  • Frantsuzoff Aleks
  • Go Chzhimin
  • Shlom Dzheffri
  • Tsang Kvong-Jok
RU2642300C2
YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA 2014
  • Rodell Timoti K.
  • Ejpelian Devid
  • Palena Klaudia
  • Shlom Dzheffri
RU2679806C2
CANCER TREATMENT USING CHIMERIC ANTIGEN-SPECIFIC RECEPTOR BASED ON HUMANISED ANTI-EGFRvIII ANTIBODY 2014
  • Brogdon Dzhennifer
  • Dzhonson Laura Aleksandra
  • Dzhun Karl Kh.
  • Lev Andreas
  • Maus Marsela
  • Sholler Dzhon
  • Okada Khidekho
RU2708032C2
MYCOBACTERIAL ANTIGEN COMPOSITION 2011
  • Kehrroll Majlz
  • Kholl Jper
  • Uill'Jams Ehnn
RU2576007C2
TREATING CANCER BY HUMANISED ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR 2014
  • Brogdon Dzhennifer
  • Dzhun Karl Kh.
  • Lev Andreas
  • Maus Marsela
  • Sholler Dzhon
RU2711975C2
INTRACELLULAR DOMAIN OF PROTEIN HER-2/NEU FOR PROPHYLAXIS AND TREATMENT OF MALIGNANCY 1996
  • Chiver Martin Eh.
  • Disis Mehri L.
RU2236461C2
MULTIVALENT VACCINE AGAINST BREAST CANCER 2013
  • Tuokhi Vinsent K.
RU2645085C2
CHIMERIC HUMAN MESOTHELIOGEN ANTIGEN RECEPTORS AND USE THEREOF 2014
  • Bitti Gregori
  • Engels Boris
  • Idamakanti Neeradzha
  • Dzhun Karl Kh.
  • Lev Andreas
  • Sun Khuejtszyuan
  • U Tsilun
RU2714902C2
INFLUENZA HAEMAGGLUTININ AND NEURAMINIDASE VARIANTS 2010
  • Dzin Khong
  • Chehn Sin
  • Subbarao Kanta
RU2535970C2

RU 2 619 850 C2

Authors

Palena Klaudia

Go Chzhimin

Ejpelian Devid

Shlom Dzheffri

Dates

2017-05-18Published

2012-03-19Filed